Literature DB >> 32753974

Development and Evaluation of a Prediction Model for Ascertaining Rheumatic Heart Disease Status in Administrative Data.

D Bond-Smith1, R Seth1, N de Klerk1,2, L Nedkoff1, M Anderson3, J Hung1, J Cannon1,2, K Griffiths4,5, J M Katzenellenbogen1,2.   

Abstract

BACKGROUND: Previous research has raised substantial concerns regarding the validity of the International Statistical Classification of Diseases and Related Health Problems (ICD) codes (ICD-10 I05-I09) for rheumatic heart disease (RHD) due to likely misclassification of non-rheumatic valvular disease (non-rheumatic VHD) as RHD. There is currently no validated, quantitative approach for reliable case ascertainment of RHD in administrative hospital data.
METHODS: A comprehensive dataset of validated Australian RHD cases was compiled and linked to inpatient hospital records with an RHD ICD code (2000-2018, n=7555). A prediction model was developed based on a generalized linear mixed model structure considering an extensive range of demographic and clinical variables. It was validated internally using randomly selected cross-validation samples and externally. Conditional optimal probability cutpoints were calculated, maximising discrimination separately for high-risk versus low-risk populations.
RESULTS: The proposed model reduced the false-positive rate (FPR) from acute rheumatic fever (ARF) cases misclassified as RHD from 0.59 to 0.27; similarly for non-rheumatic VHD from 0.77 to 0.22. Overall, the model achieved strong discriminant capacity (AUC: 0.93) and maintained a similar robust performance during external validation (AUC: 0.88). It can also be used when only basic demographic and diagnosis data are available.
CONCLUSION: This paper is the first to show that not only misclassification of non-rheumatic VHD but also of ARF as RHD yields substantial FPRs. Both sources of bias can be successfully addressed with the proposed model which provides an effective solution for reliable RHD case ascertainment from hospital data for epidemiological disease monitoring and policy evaluation.
© 2020 Bond-Smith et al.

Entities:  

Keywords:  Australia; acute rheumatic fever; administrative data; case ascertainment; discrimination; international classification of diseases; non-rheumatic valvular heart disease; prediction; receiver operating curve; rheumatic heart disease; validation

Year:  2020        PMID: 32753974      PMCID: PMC7358074          DOI: 10.2147/CLEP.S241588

Source DB:  PubMed          Journal:  Clin Epidemiol        ISSN: 1179-1349            Impact factor:   4.790


  8 in total

Review 1.  World Heart Federation criteria for echocardiographic diagnosis of rheumatic heart disease--an evidence-based guideline.

Authors:  Bo Reményi; Nigel Wilson; Andrew Steer; Beatriz Ferreira; Joseph Kado; Krishna Kumar; John Lawrenson; Graeme Maguire; Eloi Marijon; Mariana Mirabel; Ana Olga Mocumbi; Cleonice Mota; John Paar; Anita Saxena; Janet Scheel; John Stirling; Satupaitea Viali; Vijayalakshmi I Balekundri; Gavin Wheaton; Liesl Zühlke; Jonathan Carapetis
Journal:  Nat Rev Cardiol       Date:  2012-02-28       Impact factor: 32.419

2.  Low positive predictive value of International Classification of Diseases, 10th Revision codes in relation to rheumatic heart disease: a challenge for global surveillance.

Authors:  Judith M Katzenellenbogen; Lee Nedkoff; Jeffrey Cannon; Deborah Kruger; Filippa Pretty; Jonathan R Carapetis; Karen E Dempsey; Jess De Dassel; Mellise Anderson; Nicholas de Klerk; Joseph Hung
Journal:  Intern Med J       Date:  2019-03       Impact factor: 2.048

Review 3.  Acute rheumatic fever and rheumatic heart disease.

Authors:  Jonathan R Carapetis; Andrea Beaton; Madeleine W Cunningham; Luiza Guilherme; Ganesan Karthikeyan; Bongani M Mayosi; Craig Sable; Andrew Steer; Nigel Wilson; Rosemary Wyber; Liesl Zühlke
Journal:  Nat Rev Dis Primers       Date:  2016-01-14       Impact factor: 52.329

Review 4.  The global burden of group A streptococcal diseases.

Authors:  Jonathan R Carapetis; Andrew C Steer; E Kim Mulholland; Martin Weber
Journal:  Lancet Infect Dis       Date:  2005-11       Impact factor: 25.071

5.  Global, Regional, and National Burden of Rheumatic Heart Disease, 1990-2015.

Authors:  David A Watkins; Catherine O Johnson; Samantha M Colquhoun; Ganesan Karthikeyan; Andrea Beaton; Gene Bukhman; Mohammed H Forouzanfar; Christopher T Longenecker; Bongani M Mayosi; George A Mensah; Bruno R Nascimento; Antonio L P Ribeiro; Craig A Sable; Andrew C Steer; Mohsen Naghavi; Ali H Mokdad; Christopher J L Murray; Theo Vos; Jonathan R Carapetis; Gregory A Roth
Journal:  N Engl J Med       Date:  2017-08-24       Impact factor: 91.245

6.  Cross-validation for nonlinear mixed effects models.

Authors:  Emily Colby; Eric Bair
Journal:  J Pharmacokinet Pharmacodyn       Date:  2013-03-27       Impact factor: 2.745

7.  Acute rheumatic fever and rheumatic heart disease in the Kimberley: using hospitalisation data to find cases and describe trends.

Authors:  Jacqueline Murdoch; Stephanie Davis; Janice Forrester; Lynette Masuda; Carole Reeve
Journal:  Aust N Z J Public Health       Date:  2014-08-28       Impact factor: 2.939

8.  The End Rheumatic Heart Disease in Australia Study of Epidemiology (ERASE) Project: data sources, case ascertainment and cohort profile.

Authors:  Judith M Katzenellenbogen; Daniela Bond-Smith; Rebecca J Seth; Karen Dempsey; Jeffrey Cannon; Lee Nedkoff; Frank M Sanfilippo; Nicholas de Klerk; Joe Hung; Elizabeth Geelhoed; Daniel Williamson; Rosemary Wyber; Anna P Ralph; Dawn Bessarab
Journal:  Clin Epidemiol       Date:  2019-11-15       Impact factor: 4.790

  8 in total
  2 in total

1.  Long-term outcomes following rheumatic heart disease diagnosis in Australia.

Authors:  Ingrid Stacey; Joseph Hung; Jeff Cannon; Rebecca J Seth; Bo Remenyi; Daniela Bond-Smith; Kalinda Griffiths; Frank Sanfilippo; Jonathan Carapetis; Kevin Murray; Judith M Katzenellenbogen
Journal:  Eur Heart J Open       Date:  2021-11-09

2.  The use of cardiac valve procedures for rheumatic heart disease in Australia; a cross-sectional study 2002-2017.

Authors:  Pamela J Bradshaw; Hideo Tohira; James Marangou; Mark Newman; Bo Reményi; Vicki Wade; Christopher Reid; Judith M Katzenellenbogen
Journal:  Ann Med Surg (Lond)       Date:  2020-11-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.